First Personal Financial Services Supernus Pharmaceuticals, Inc. Transaction History

First Personal Financial Services

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 15, 2019	SELL	$25.47 - $33.37 $2,750 - $3,603	-108 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$44.1 - $59.85 $6,394 - $8,678	-145 Reduced 57.31%	108 $6,000
Q1 2018 May 10, 2018	SELL	$37.15 - $46.9 $74 - $93	-2 Reduced 0.78%	253 $12,000
Q4 2017 Jan 25, 2018	BUY	$36.4 - $42.6 $3,130 - $3,663	86 Added 50.89%	255 $10,000
Q3 2017 Nov 01, 2017	BUY	$36.75 - $49.65 $6,210 - $8,390	169	169 $7,000

260

57.3M

84.1K

61.2K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.39B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of First Personal Financial Services, based on Form 13F filings with the SEC.

Stay updated on First Personal Financial Services with notifications on news.